Recon: FDA to get less funding in Senate budget bill for FY 2023 compared to House version; EU funders fail to measure clinical trial transparency
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyGlobalMedical DevicesPharmaceuticals